Following the exciting announcement that ICOS the manufacturer of Cialis is to seek approval from the EMEA for a one a day version of its erectile dysfunction medication the shares in the company rose by 7.3%. The rise was not solely attributed to the announcement but also the fact that the Cialis drug is selling well and taking market share from Viagra and Levitra its two big rivals in the impotence drug market.Heavy trading accompanied the share price rise and they ended up at a price of 21.59 dollars.

ICOS is forecasting a net loss in 2006 to be of the region of 8c to 39c per share and is hoping for earnings of 53c to 68c in the following year, as well as 1.23 dollars to 1.45 dollars of earnings per share in 2008.

An official application has been filed with the European Medicines Agency (EMEA) for the low dose versions of Cialis. They will be 2.5mg and 5mg doses and are designed to be taken everyday as opposed to only in anticipation of sexual activity. The one a day version will cost more in the long run but this should bring bigger profits to ICOS and will also mean that the men with impotence problems who use Cialis Once a Day will be constantly ready for sex.

Eventually the drug will also be sold in the United States and Canada provided that regulatory hurdles are overcome there too. The US market for erectile dysfunction drugs is will be the source of much of ICOS's future profits. Expect to see Cialis Once a Day on the shelves in pharmacies by the year 2007.

Cialis can only be taken with a doctors prescription and is the only erectile dysfunction drug that lasts for more than a day. In France it is the best selling impotence medication and is nicknamed the weekend pill. Cialis at present comes in 3 doses of 5mg, 10mg and 20 mg.